

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.59876993 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.00350210 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.00350210 |
| 4 | cytidine metabolic process (GO:0046087) | 4.93925251 |
| 5 | cytidine catabolic process (GO:0006216) | 4.93925251 |
| 6 | cytidine deamination (GO:0009972) | 4.93925251 |
| 7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.84541804 |
| 8 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.77327652 |
| 9 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.69785831 |
| 10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.63519004 |
| 11 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.60837569 |
| 12 | DNA deamination (GO:0045006) | 4.59522961 |
| 13 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.38947523 |
| 14 | cellular response to interleukin-15 (GO:0071350) | 4.19775693 |
| 15 | regulation of regulatory T cell differentiation (GO:0045589) | 4.13258849 |
| 16 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.08008504 |
| 17 | positive regulation of tolerance induction (GO:0002645) | 4.01515070 |
| 18 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 4.01133872 |
| 19 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.00195423 |
| 20 | positive regulation of defense response to virus by host (GO:0002230) | 3.85411069 |
| 21 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.80371353 |
| 22 | regulation of T cell tolerance induction (GO:0002664) | 3.72888968 |
| 23 | axonemal dynein complex assembly (GO:0070286) | 3.70510659 |
| 24 | regulation of cell killing (GO:0031341) | 3.64652920 |
| 25 | response to interleukin-15 (GO:0070672) | 3.61539026 |
| 26 | regulation of tolerance induction (GO:0002643) | 3.59215489 |
| 27 | negative T cell selection (GO:0043383) | 3.58827047 |
| 28 | regulation of activation of Janus kinase activity (GO:0010533) | 3.58728543 |
| 29 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.57739653 |
| 30 | positive regulation of cell killing (GO:0031343) | 3.55663612 |
| 31 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.50450334 |
| 32 | positive thymic T cell selection (GO:0045059) | 3.45672264 |
| 33 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.45508176 |
| 34 | GDP-mannose metabolic process (GO:0019673) | 3.43169964 |
| 35 | interferon-gamma production (GO:0032609) | 3.42948735 |
| 36 | immunoglobulin mediated immune response (GO:0016064) | 3.40392716 |
| 37 | tolerance induction (GO:0002507) | 3.35453207 |
| 38 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.34528808 |
| 39 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.34528808 |
| 40 | regulation of chronic inflammatory response (GO:0002676) | 3.33199323 |
| 41 | NIK/NF-kappaB signaling (GO:0038061) | 3.31909863 |
| 42 | negative thymic T cell selection (GO:0045060) | 3.31563193 |
| 43 | cellular response to type I interferon (GO:0071357) | 3.30857685 |
| 44 | type I interferon signaling pathway (GO:0060337) | 3.30857685 |
| 45 | response to type I interferon (GO:0034340) | 3.30836178 |
| 46 | positive T cell selection (GO:0043368) | 3.28981971 |
| 47 | mast cell activation (GO:0045576) | 3.28028332 |
| 48 | positive regulation of T cell mediated immunity (GO:0002711) | 3.24875801 |
| 49 | response to interferon-beta (GO:0035456) | 3.24070707 |
| 50 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.22342169 |
| 51 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.18416241 |
| 52 | negative regulation of viral genome replication (GO:0045071) | 3.14318372 |
| 53 | regulation of T cell mediated immunity (GO:0002709) | 3.10223828 |
| 54 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.09826211 |
| 55 | regulation of memory T cell differentiation (GO:0043380) | 3.09587855 |
| 56 | cilium movement (GO:0003341) | 3.06261654 |
| 57 | regulation of gamma-delta T cell activation (GO:0046643) | 3.05668158 |
| 58 | actin nucleation (GO:0045010) | 3.04281838 |
| 59 | axoneme assembly (GO:0035082) | 3.01834122 |
| 60 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.01621591 |
| 61 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.98610636 |
| 62 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.97811427 |
| 63 | epithelial cilium movement (GO:0003351) | 2.95289740 |
| 64 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.94456526 |
| 65 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.89623101 |
| 66 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.85383876 |
| 67 | regulation of defense response to virus by host (GO:0050691) | 2.84238243 |
| 68 | B cell mediated immunity (GO:0019724) | 2.83856390 |
| 69 | negative regulation of T cell apoptotic process (GO:0070233) | 2.79049010 |
| 70 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.77930103 |
| 71 | thymic T cell selection (GO:0045061) | 2.77809243 |
| 72 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.77425112 |
| 73 | negative regulation of T cell mediated immunity (GO:0002710) | 2.76616503 |
| 74 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.76509439 |
| 75 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.75124208 |
| 76 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 2.74581793 |
| 77 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.74210350 |
| 78 | T cell selection (GO:0045058) | 2.73639460 |
| 79 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.73157576 |
| 80 | motile cilium assembly (GO:0044458) | 2.73069315 |
| 81 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.72514696 |
| 82 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.70934413 |
| 83 | positive regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.69690443 |
| 84 | mast cell degranulation (GO:0043303) | 2.66669182 |
| 85 | mast cell activation involved in immune response (GO:0002279) | 2.66669182 |
| 86 | positive regulation of lymphocyte migration (GO:2000403) | 2.65005881 |
| 87 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.64718157 |
| 88 | cellular defense response (GO:0006968) | 2.64160328 |
| 89 | positive regulation of interleukin-17 production (GO:0032740) | 2.63647574 |
| 90 | lymph node development (GO:0048535) | 2.63471232 |
| 91 | regulation of T-helper 1 type immune response (GO:0002825) | 2.62318815 |
| 92 | mannose metabolic process (GO:0006013) | 2.61267798 |
| 93 | regulation of germinal center formation (GO:0002634) | 2.60496277 |
| 94 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.60319631 |
| 95 | activated T cell proliferation (GO:0050798) | 2.58982174 |
| 96 | positive regulation of adaptive immune response (GO:0002821) | 2.58591496 |
| 97 | regulation of lymphocyte mediated immunity (GO:0002706) | 2.57819104 |
| 98 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.57402427 |
| 99 | regulation of T cell migration (GO:2000404) | 2.56583390 |
| 100 | T cell costimulation (GO:0031295) | 2.56300514 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.94520434 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.25214756 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.79814582 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.97237484 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.65754316 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.51019968 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.00180633 |
| 8 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.85332536 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.77934704 |
| 10 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.71303191 |
| 11 | MYB_26560356_Chip-Seq_TH2_Human | 2.36621751 |
| 12 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.25079690 |
| 13 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.09103568 |
| 14 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.01145795 |
| 15 | GATA3_26560356_Chip-Seq_TH2_Human | 2.00566898 |
| 16 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98522844 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96731820 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.69257400 |
| 19 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.67351628 |
| 20 | MYB_26560356_Chip-Seq_TH1_Human | 1.60611723 |
| 21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.59406391 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.56621104 |
| 23 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.49925224 |
| 24 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.48857667 |
| 25 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.48758168 |
| 26 | UTX_26944678_Chip-Seq_JUKART_Human | 1.48184748 |
| 27 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.43687934 |
| 28 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.43008562 |
| 29 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.42364502 |
| 30 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41876449 |
| 31 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.38466052 |
| 32 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.38057624 |
| 33 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.37983085 |
| 34 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.37979703 |
| 35 | MAF_26560356_Chip-Seq_TH1_Human | 1.37222312 |
| 36 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.36754059 |
| 37 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.36390953 |
| 38 | P300_27268052_Chip-Seq_Bcells_Human | 1.34875786 |
| 39 | MAF_26560356_Chip-Seq_TH2_Human | 1.31417113 |
| 40 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.30094690 |
| 41 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29121863 |
| 42 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.27482151 |
| 43 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.27482151 |
| 44 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.26891367 |
| 45 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.25549709 |
| 46 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.24707650 |
| 47 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.22972505 |
| 48 | VDR_22108803_ChIP-Seq_LS180_Human | 1.21966865 |
| 49 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.21878214 |
| 50 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.21398449 |
| 51 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.21202400 |
| 52 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.20815678 |
| 53 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19947055 |
| 54 | AR_20517297_ChIP-Seq_VCAP_Human | 1.19880607 |
| 55 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.18339755 |
| 56 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.17537696 |
| 57 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.16918814 |
| 58 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.16816353 |
| 59 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.15226621 |
| 60 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.11570807 |
| 61 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.11109619 |
| 62 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.09327829 |
| 63 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.09200522 |
| 64 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.09059323 |
| 65 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.07563435 |
| 66 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.06648930 |
| 67 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.05083848 |
| 68 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.04196979 |
| 69 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.03890389 |
| 70 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.03554781 |
| 71 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.03553564 |
| 72 | SA1_27219007_Chip-Seq_Bcells_Human | 1.03267462 |
| 73 | SPI1_23127762_ChIP-Seq_K562_Human | 1.01811515 |
| 74 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.00880165 |
| 75 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.00051976 |
| 76 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.99861309 |
| 77 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.98768190 |
| 78 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.97668485 |
| 79 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.97249533 |
| 80 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.97221765 |
| 81 | ERA_21632823_ChIP-Seq_H3396_Human | 0.96974266 |
| 82 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.96856704 |
| 83 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.96768803 |
| 84 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.96595329 |
| 85 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.96315586 |
| 86 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.96031857 |
| 87 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.95513527 |
| 88 | NCOR_22424771_ChIP-Seq_293T_Human | 0.94681592 |
| 89 | GATA3_26560356_Chip-Seq_TH1_Human | 0.93096246 |
| 90 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.90669890 |
| 91 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.90296213 |
| 92 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.88990257 |
| 93 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.87510012 |
| 94 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.86107638 |
| 95 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.86032502 |
| 96 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.85309349 |
| 97 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85163430 |
| 98 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85077992 |
| 99 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.84855164 |
| 100 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.84668605 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.66025567 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.98725211 |
| 3 | MP0003436_decreased_susceptibility_to | 3.07995531 |
| 4 | MP0001790_abnormal_immune_system | 3.05353803 |
| 5 | MP0005387_immune_system_phenotype | 3.05353803 |
| 6 | MP0009785_altered_susceptibility_to | 3.04536939 |
| 7 | MP0003724_increased_susceptibility_to | 2.94214729 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.87833215 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 2.84578226 |
| 10 | MP0000685_abnormal_immune_system | 2.82433155 |
| 11 | MP0001800_abnormal_humoral_immune | 2.77019866 |
| 12 | MP0003763_abnormal_thymus_physiology | 2.75609348 |
| 13 | MP0005025_abnormal_response_to | 2.51996101 |
| 14 | MP0002723_abnormal_immune_serum | 2.51135423 |
| 15 | MP0006082_CNS_inflammation | 2.39742968 |
| 16 | MP0010155_abnormal_intestine_physiology | 2.31354888 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.27084364 |
| 18 | MP0001819_abnormal_immune_cell | 2.24845971 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.19898455 |
| 20 | MP0009333_abnormal_splenocyte_physiolog | 2.10514348 |
| 21 | MP0002419_abnormal_innate_immunity | 1.89195691 |
| 22 | MP0001873_stomach_inflammation | 1.78499458 |
| 23 | MP0003866_abnormal_defecation | 1.78069493 |
| 24 | MP0001845_abnormal_inflammatory_respons | 1.77961593 |
| 25 | MP0008875_abnormal_xenobiotic_pharmacok | 1.76565360 |
| 26 | MP0002405_respiratory_system_inflammati | 1.75398225 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.75361406 |
| 28 | MP0009764_decreased_sensitivity_to | 1.71901197 |
| 29 | MP0000716_abnormal_immune_system | 1.70683644 |
| 30 | MP0001533_abnormal_skeleton_physiology | 1.67267513 |
| 31 | MP0004043_abnormal_pH_regulation | 1.65112192 |
| 32 | MP0002638_abnormal_pupillary_reflex | 1.64825416 |
| 33 | MP0002398_abnormal_bone_marrow | 1.64027569 |
| 34 | MP0002166_altered_tumor_susceptibility | 1.59680271 |
| 35 | MP0002876_abnormal_thyroid_physiology | 1.57046981 |
| 36 | MP0004147_increased_porphyrin_level | 1.56622403 |
| 37 | MP0002139_abnormal_hepatobiliary_system | 1.52211846 |
| 38 | MP0002933_joint_inflammation | 1.51585395 |
| 39 | MP0001501_abnormal_sleep_pattern | 1.50841538 |
| 40 | MP0005464_abnormal_platelet_physiology | 1.49572329 |
| 41 | MP0002277_abnormal_respiratory_mucosa | 1.45049708 |
| 42 | MP0004947_skin_inflammation | 1.41662457 |
| 43 | MP0008469_abnormal_protein_level | 1.41273389 |
| 44 | MP0000689_abnormal_spleen_morphology | 1.40640570 |
| 45 | MP0002722_abnormal_immune_system | 1.37682461 |
| 46 | MP0003646_muscle_fatigue | 1.36786780 |
| 47 | MP0002006_tumorigenesis | 1.33034143 |
| 48 | MP0002132_abnormal_respiratory_system | 1.32257463 |
| 49 | MP0002429_abnormal_blood_cell | 1.28161027 |
| 50 | MP0005645_abnormal_hypothalamus_physiol | 1.27176104 |
| 51 | MP0005075_abnormal_melanosome_morpholog | 1.23391511 |
| 52 | MP0000703_abnormal_thymus_morphology | 1.20165817 |
| 53 | MP0006072_abnormal_retinal_apoptosis | 1.19103879 |
| 54 | MP0008872_abnormal_physiological_respon | 1.16847346 |
| 55 | MP0005360_urolithiasis | 1.15947584 |
| 56 | MP0003878_abnormal_ear_physiology | 1.15271627 |
| 57 | MP0005377_hearing/vestibular/ear_phenot | 1.15271627 |
| 58 | MP0003303_peritoneal_inflammation | 1.12328671 |
| 59 | MP0000465_gastrointestinal_hemorrhage | 1.10977033 |
| 60 | MP0005410_abnormal_fertilization | 1.08360932 |
| 61 | MP0001765_abnormal_ion_homeostasis | 1.06473044 |
| 62 | MP0002837_dystrophic_cardiac_calcinosis | 1.05581279 |
| 63 | MP0002693_abnormal_pancreas_physiology | 1.00854431 |
| 64 | MP0005166_decreased_susceptibility_to | 1.00336512 |
| 65 | MP0003806_abnormal_nucleotide_metabolis | 0.99101794 |
| 66 | MP0001919_abnormal_reproductive_system | 0.93466332 |
| 67 | MP0003075_altered_response_to | 0.91785506 |
| 68 | MP0009840_abnormal_foam_cell | 0.89953398 |
| 69 | MP0001853_heart_inflammation | 0.89487698 |
| 70 | MP0005310_abnormal_salivary_gland | 0.89460135 |
| 71 | MP0001986_abnormal_taste_sensitivity | 0.88834431 |
| 72 | MP0003195_calcinosis | 0.87879067 |
| 73 | MP0005174_abnormal_tail_pigmentation | 0.86940071 |
| 74 | MP0009643_abnormal_urine_homeostasis | 0.84641046 |
| 75 | MP0002136_abnormal_kidney_physiology | 0.83885739 |
| 76 | MP0009763_increased_sensitivity_to | 0.83040898 |
| 77 | MP0005167_abnormal_blood-brain_barrier | 0.80786596 |
| 78 | MP0002254_reproductive_system_inflammat | 0.79576705 |
| 79 | MP0004019_abnormal_vitamin_homeostasis | 0.78546316 |
| 80 | MP0005365_abnormal_bile_salt | 0.77941629 |
| 81 | MP0005646_abnormal_pituitary_gland | 0.77135216 |
| 82 | MP0005636_abnormal_mineral_homeostasis | 0.76739870 |
| 83 | MP0005253_abnormal_eye_physiology | 0.76687014 |
| 84 | MP0000372_irregular_coat_pigmentation | 0.75789240 |
| 85 | MP0005379_endocrine/exocrine_gland_phen | 0.75569503 |
| 86 | MP0001764_abnormal_homeostasis | 0.74171193 |
| 87 | MP0005389_reproductive_system_phenotype | 0.73198339 |
| 88 | MP0001663_abnormal_digestive_system | 0.72293493 |
| 89 | MP0005535_abnormal_body_temperature | 0.70709412 |
| 90 | MP0001905_abnormal_dopamine_level | 0.70044425 |
| 91 | MP0002998_abnormal_bone_remodeling | 0.69628098 |
| 92 | MP0002653_abnormal_ependyma_morphology | 0.68518268 |
| 93 | MP0006036_abnormal_mitochondrial_physio | 0.68098658 |
| 94 | MP0005551_abnormal_eye_electrophysiolog | 0.67921485 |
| 95 | MP0005390_skeleton_phenotype | 0.66076087 |
| 96 | MP0002102_abnormal_ear_morphology | 0.65342310 |
| 97 | MP0000230_abnormal_systemic_arterial | 0.65237872 |
| 98 | MP0005085_abnormal_gallbladder_physiolo | 0.64470260 |
| 99 | MP0002163_abnormal_gland_morphology | 0.64219037 |
| 100 | MP0010329_abnormal_lipoprotein_level | 0.63729234 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.86019681 |
| 2 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 4.55291756 |
| 3 | Absent/shortened dynein arms (HP:0200106) | 4.55291756 |
| 4 | Abnormality of T cell number (HP:0011839) | 4.11223746 |
| 5 | T lymphocytopenia (HP:0005403) | 4.08380773 |
| 6 | Myositis (HP:0100614) | 3.97997643 |
| 7 | IgG deficiency (HP:0004315) | 3.91651888 |
| 8 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.88217931 |
| 9 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.88217931 |
| 10 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.87369714 |
| 11 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.83475190 |
| 12 | Abnormal ciliary motility (HP:0012262) | 3.72928320 |
| 13 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.57820279 |
| 14 | Stomatitis (HP:0010280) | 3.55039745 |
| 15 | Orchitis (HP:0100796) | 3.33183343 |
| 16 | Severe combined immunodeficiency (HP:0004430) | 3.30933217 |
| 17 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.30563741 |
| 18 | Abnormality of T cells (HP:0002843) | 3.28478442 |
| 19 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.25902417 |
| 20 | Optic neuritis (HP:0100653) | 3.24629758 |
| 21 | Retrobulbar optic neuritis (HP:0100654) | 3.24629758 |
| 22 | Bronchiectasis (HP:0002110) | 3.20538992 |
| 23 | Nasal polyposis (HP:0100582) | 3.15537103 |
| 24 | Increased IgM level (HP:0003496) | 3.12838538 |
| 25 | Abnormality of eosinophils (HP:0001879) | 3.11395404 |
| 26 | Rhinitis (HP:0012384) | 3.07694790 |
| 27 | Recurrent bronchitis (HP:0002837) | 2.92053544 |
| 28 | Eosinophilia (HP:0001880) | 2.91002203 |
| 29 | Hypoproteinemia (HP:0003075) | 2.85637948 |
| 30 | Congenital stationary night blindness (HP:0007642) | 2.84870100 |
| 31 | Chronic sinusitis (HP:0011109) | 2.76355742 |
| 32 | Bronchitis (HP:0012387) | 2.70773689 |
| 33 | Thyroiditis (HP:0100646) | 2.70579087 |
| 34 | Abnormality of the nasal mucosa (HP:0000433) | 2.69984279 |
| 35 | Encephalitis (HP:0002383) | 2.69364036 |
| 36 | Abnormality of B cell number (HP:0010975) | 2.63120717 |
| 37 | 3-Methylglutaconic aciduria (HP:0003535) | 2.62101484 |
| 38 | Autoimmune hemolytic anemia (HP:0001890) | 2.61279084 |
| 39 | Granulocytopenia (HP:0001913) | 2.58946292 |
| 40 | Recurrent cutaneous fungal infections (HP:0011370) | 2.57435796 |
| 41 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.57435796 |
| 42 | Abnormality of T cell physiology (HP:0011840) | 2.56088483 |
| 43 | Pulmonary infiltrates (HP:0002113) | 2.55733052 |
| 44 | Recurrent sinusitis (HP:0011108) | 2.55277886 |
| 45 | Leukocytosis (HP:0001974) | 2.54781607 |
| 46 | Vasculitis (HP:0002633) | 2.52699737 |
| 47 | Panhypogammaglobulinemia (HP:0003139) | 2.51883854 |
| 48 | Chronic diarrhea (HP:0002028) | 2.46537743 |
| 49 | Pustule (HP:0200039) | 2.43965934 |
| 50 | Recurrent fungal infections (HP:0002841) | 2.43959596 |
| 51 | Combined immunodeficiency (HP:0005387) | 2.43076483 |
| 52 | Chronic bronchitis (HP:0004469) | 2.39821172 |
| 53 | Chronic otitis media (HP:0000389) | 2.39376542 |
| 54 | Meningitis (HP:0001287) | 2.32551907 |
| 55 | Decreased central vision (HP:0007663) | 2.26862672 |
| 56 | Gastrointestinal infarctions (HP:0005244) | 2.20543426 |
| 57 | Constricted visual fields (HP:0001133) | 2.19860782 |
| 58 | Abnormality of the renal cortex (HP:0011035) | 2.19663194 |
| 59 | Keratoconjunctivitis (HP:0001096) | 2.17741418 |
| 60 | Mediastinal lymphadenopathy (HP:0100721) | 2.17548040 |
| 61 | Keratoconjunctivitis sicca (HP:0001097) | 2.13158459 |
| 62 | Decreased circulating renin level (HP:0003351) | 2.11424524 |
| 63 | B lymphocytopenia (HP:0010976) | 2.09341069 |
| 64 | Attenuation of retinal blood vessels (HP:0007843) | 2.09017303 |
| 65 | Joint swelling (HP:0001386) | 2.07132302 |
| 66 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.02754245 |
| 67 | Pancreatic cysts (HP:0001737) | 2.01464540 |
| 68 | Autoimmune thrombocytopenia (HP:0001973) | 2.00747781 |
| 69 | Hemoptysis (HP:0002105) | 1.99113021 |
| 70 | Type II lissencephaly (HP:0007260) | 1.98484785 |
| 71 | Hypergammaglobulinemia (HP:0010702) | 1.96302868 |
| 72 | Renal cortical cysts (HP:0000803) | 1.95293096 |
| 73 | Abnormality of macrophages (HP:0004311) | 1.94721448 |
| 74 | Abnormality of the pleura (HP:0002103) | 1.94274073 |
| 75 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.93072092 |
| 76 | Abnormality of midbrain morphology (HP:0002418) | 1.92899457 |
| 77 | Molar tooth sign on MRI (HP:0002419) | 1.92899457 |
| 78 | Abolished electroretinogram (ERG) (HP:0000550) | 1.90634690 |
| 79 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.90333648 |
| 80 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.90333648 |
| 81 | Recurrent skin infections (HP:0001581) | 1.90035247 |
| 82 | Nephronophthisis (HP:0000090) | 1.89755633 |
| 83 | Global brain atrophy (HP:0002283) | 1.89491988 |
| 84 | Recurrent viral infections (HP:0004429) | 1.88535403 |
| 85 | Eczematoid dermatitis (HP:0000976) | 1.87110504 |
| 86 | Recurrent bacterial skin infections (HP:0005406) | 1.85626043 |
| 87 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.85419867 |
| 88 | Polydipsia (HP:0001959) | 1.84592675 |
| 89 | Abnormal drinking behavior (HP:0030082) | 1.84592675 |
| 90 | Agammaglobulinemia (HP:0004432) | 1.84234640 |
| 91 | Recurrent otitis media (HP:0000403) | 1.79201929 |
| 92 | Inflammation of the large intestine (HP:0002037) | 1.79152156 |
| 93 | Recurrent abscess formation (HP:0002722) | 1.78170491 |
| 94 | Increased intramyocellular lipid droplets (HP:0012240) | 1.77783980 |
| 95 | Pulmonary embolism (HP:0002204) | 1.76999838 |
| 96 | Gangrene (HP:0100758) | 1.75944067 |
| 97 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.74440026 |
| 98 | Abnormality of the prostate (HP:0008775) | 1.74054239 |
| 99 | Alkalosis (HP:0001948) | 1.73766020 |
| 100 | Anorexia (HP:0002039) | 1.72130587 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 4.64644013 |
| 2 | MAP4K1 | 3.58873417 |
| 3 | TLK1 | 3.40351291 |
| 4 | TAOK3 | 2.72243529 |
| 5 | TESK2 | 2.60281759 |
| 6 | ADRBK2 | 2.46988080 |
| 7 | KDR | 2.43522774 |
| 8 | GRK6 | 2.26301663 |
| 9 | PINK1 | 2.25129761 |
| 10 | FES | 2.21011412 |
| 11 | RIPK4 | 2.14786811 |
| 12 | ZAK | 1.99373191 |
| 13 | IKBKE | 1.98314558 |
| 14 | TBK1 | 1.92455365 |
| 15 | ERN1 | 1.92352849 |
| 16 | ZAP70 | 1.88026033 |
| 17 | FRK | 1.84577492 |
| 18 | ITK | 1.77879031 |
| 19 | MAP4K2 | 1.76667901 |
| 20 | TIE1 | 1.72205222 |
| 21 | GRK1 | 1.71821870 |
| 22 | SYK | 1.68110810 |
| 23 | KIT | 1.66958573 |
| 24 | WNK4 | 1.62873484 |
| 25 | IKBKB | 1.60025663 |
| 26 | TEC | 1.57784950 |
| 27 | MAP2K6 | 1.56975826 |
| 28 | CSK | 1.54944443 |
| 29 | MAP3K14 | 1.54567364 |
| 30 | LCK | 1.54408274 |
| 31 | BTK | 1.49461155 |
| 32 | BCKDK | 1.46434901 |
| 33 | IRAK4 | 1.42164538 |
| 34 | JAK3 | 1.41200969 |
| 35 | PRKCQ | 1.38886890 |
| 36 | MAPK15 | 1.35552724 |
| 37 | TYK2 | 1.31222823 |
| 38 | MST4 | 1.28590338 |
| 39 | ACVR1B | 1.25553332 |
| 40 | TNK2 | 1.25322675 |
| 41 | TESK1 | 1.20815790 |
| 42 | MAP2K2 | 1.18635243 |
| 43 | MATK | 1.12864995 |
| 44 | JAK1 | 1.10709136 |
| 45 | MAP3K11 | 1.09195840 |
| 46 | CSF1R | 1.06808340 |
| 47 | LYN | 1.05770806 |
| 48 | MAPKAPK3 | 0.99080256 |
| 49 | MARK3 | 0.97904419 |
| 50 | GRK7 | 0.96815532 |
| 51 | DAPK2 | 0.95657679 |
| 52 | LIMK1 | 0.94700334 |
| 53 | HCK | 0.92338860 |
| 54 | NUAK1 | 0.89783467 |
| 55 | BMPR2 | 0.84407719 |
| 56 | BLK | 0.80331412 |
| 57 | CAMKK2 | 0.71789811 |
| 58 | PIM1 | 0.69123610 |
| 59 | VRK1 | 0.68420203 |
| 60 | MUSK | 0.66888367 |
| 61 | PASK | 0.59512120 |
| 62 | EPHA3 | 0.57315502 |
| 63 | PDK1 | 0.54917787 |
| 64 | VRK2 | 0.54649193 |
| 65 | TRPM7 | 0.54537471 |
| 66 | PTK2B | 0.54251240 |
| 67 | RPS6KA5 | 0.52762262 |
| 68 | MAPK11 | 0.48652101 |
| 69 | MAP3K3 | 0.48078894 |
| 70 | PHKG2 | 0.45878425 |
| 71 | PHKG1 | 0.45878425 |
| 72 | INSRR | 0.45682195 |
| 73 | IGF1R | 0.45653023 |
| 74 | MYLK | 0.44522355 |
| 75 | NLK | 0.42652962 |
| 76 | ABL1 | 0.42595806 |
| 77 | ADRBK1 | 0.39816110 |
| 78 | FYN | 0.39125754 |
| 79 | BMPR1B | 0.38766753 |
| 80 | CSNK1G3 | 0.38519165 |
| 81 | HIPK2 | 0.35828090 |
| 82 | CDC42BPA | 0.35673376 |
| 83 | CHUK | 0.34871569 |
| 84 | EPHB1 | 0.34645533 |
| 85 | PRKCA | 0.32032773 |
| 86 | MAPKAPK2 | 0.31599732 |
| 87 | PRKCD | 0.31030890 |
| 88 | EGFR | 0.30964306 |
| 89 | IRAK1 | 0.30909973 |
| 90 | CDK8 | 0.30587529 |
| 91 | DAPK1 | 0.30318099 |
| 92 | JAK2 | 0.30124357 |
| 93 | PIM2 | 0.27779475 |
| 94 | SIK2 | 0.27355975 |
| 95 | INSR | 0.26723998 |
| 96 | PRKCI | 0.25822573 |
| 97 | PRKG2 | 0.25061985 |
| 98 | WNK3 | 0.24401130 |
| 99 | PDPK1 | 0.23419373 |
| 100 | CAMKK1 | 0.23270524 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.07135519 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.94553612 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.88646162 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.74358191 |
| 5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.34424291 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.19693116 |
| 7 | Asthma_Homo sapiens_hsa05310 | 2.94407127 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.86326682 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.44399142 |
| 10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.27368810 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.13988907 |
| 12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.91836595 |
| 13 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.91084784 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.87108253 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.80252628 |
| 16 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.61910070 |
| 17 | Viral myocarditis_Homo sapiens_hsa05416 | 1.60420064 |
| 18 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.59665058 |
| 19 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.58834801 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.51126460 |
| 21 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.50122219 |
| 22 | Leishmaniasis_Homo sapiens_hsa05140 | 1.49955936 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.43161480 |
| 24 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.31545497 |
| 25 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.27416446 |
| 26 | Proteasome_Homo sapiens_hsa03050 | 1.23847588 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.22161543 |
| 28 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.21623434 |
| 29 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.20928932 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.20925953 |
| 31 | Phototransduction_Homo sapiens_hsa04744 | 1.18237450 |
| 32 | Measles_Homo sapiens_hsa05162 | 1.15999796 |
| 33 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.08833794 |
| 34 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.07704263 |
| 35 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.05706797 |
| 36 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.05491889 |
| 37 | Malaria_Homo sapiens_hsa05144 | 1.03025767 |
| 38 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.02777621 |
| 39 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.02365183 |
| 40 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.97091706 |
| 41 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.95187642 |
| 42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.94139336 |
| 43 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.92067523 |
| 44 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.90994555 |
| 45 | Peroxisome_Homo sapiens_hsa04146 | 0.90405124 |
| 46 | Tuberculosis_Homo sapiens_hsa05152 | 0.88476709 |
| 47 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.88419639 |
| 48 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.86099577 |
| 49 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.80578542 |
| 50 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.77501182 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 0.76708149 |
| 52 | Pertussis_Homo sapiens_hsa05133 | 0.75812196 |
| 53 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.75667655 |
| 54 | Retinol metabolism_Homo sapiens_hsa00830 | 0.70412667 |
| 55 | Olfactory transduction_Homo sapiens_hsa04740 | 0.69335660 |
| 56 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.68453529 |
| 57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.67948182 |
| 58 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.66773583 |
| 59 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.66123100 |
| 60 | Influenza A_Homo sapiens_hsa05164 | 0.65360459 |
| 61 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.64522286 |
| 62 | Legionellosis_Homo sapiens_hsa05134 | 0.63844148 |
| 63 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.62786938 |
| 64 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.61420889 |
| 65 | Lysosome_Homo sapiens_hsa04142 | 0.60590250 |
| 66 | Parkinsons disease_Homo sapiens_hsa05012 | 0.60514185 |
| 67 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.60099295 |
| 68 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.59777952 |
| 69 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.55611626 |
| 70 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.54455797 |
| 71 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.53705100 |
| 72 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.52115429 |
| 73 | Phagosome_Homo sapiens_hsa04145 | 0.50436136 |
| 74 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.49185849 |
| 75 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.49144290 |
| 76 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.48310945 |
| 77 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.47756766 |
| 78 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.46817854 |
| 79 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.45549314 |
| 80 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.44566286 |
| 81 | Huntingtons disease_Homo sapiens_hsa05016 | 0.41765091 |
| 82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40294718 |
| 83 | Mineral absorption_Homo sapiens_hsa04978 | 0.37796637 |
| 84 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.37587576 |
| 85 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.35910713 |
| 86 | Alzheimers disease_Homo sapiens_hsa05010 | 0.35908048 |
| 87 | Other glycan degradation_Homo sapiens_hsa00511 | 0.35316603 |
| 88 | Shigellosis_Homo sapiens_hsa05131 | 0.31594260 |
| 89 | Salmonella infection_Homo sapiens_hsa05132 | 0.31275117 |
| 90 | Histidine metabolism_Homo sapiens_hsa00340 | 0.29309894 |
| 91 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.28740582 |
| 92 | Apoptosis_Homo sapiens_hsa04210 | 0.25938817 |
| 93 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.25356492 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | 0.23290428 |
| 95 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.23275160 |
| 96 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.23011988 |
| 97 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.22424326 |
| 98 | RNA degradation_Homo sapiens_hsa03018 | 0.21075607 |
| 99 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.20395184 |
| 100 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.20240196 |

